Description
The difference
Unlock Your Potential
Each vial contains a blend of CJC-1295 (NO DAC) + Ipamorelin.
Ipamorelin is one of the most selective growth hormone (GH) secretagogues known and a potent agonist of the ghrelin/growth hormone secretagogue receptor.
CJC-1295 also causes the release of GH, but it does so by stimulating the growth hormone releasing hormone receptor. By combing the two peptides, it may be possible to produce enhanced effects because they stimulate the growth  hormone axis via two different mechanisms. Research using both peptides is likely to show increased benefit without substantially increased side effects.
Ipamorelin is likely to raise baseline levels of GH such that CJC-1295 will be able to produce both higher peaks and higher troughs while preserving normal growth hormone pulsatile secretion. The net  effect of combing the peptides would be a higher set point for the normal ebb and flow of GH.
What is CJC-1295?
CJC-1295 & Ipamorelin Peptide Blend
Ipamorelin and CJC-1295 are both considered to be growth hormone secretagogues. Ipamorelin is a synthetic pentapeptide,and CJC-1295 peptide consists of 29 amino acids. Ipamorelin appears to fall into a category of peptides classified as growth hormone secretagogues (GHSs). These are peptides that are assumed to stimulate the release of the growth hormones, however are not considered growth hormone releasing peptides themselves. On the other hand, CJC-1295 has also been suggested by researchers to stimulate the release of growth hormone, primarily by mimicking the actions of the naturally occurring growth hormone-releasing hormone (GHRH). Both Ipamorelin and CJC-1295 peptides have been assigned by researchers to this class, studied for similar potential actions and apparently differing only in terms of their half-life and pharmacokinetic profiles.
There are no reviews yet.